CRANBURY, N.J.--(BUSINESS WIRE)--OncLive®, the leading digital provider of resources and information to oncology professionals, surpassed 713,777-page views on Onclive.com for the month of October, announced Michael J. Hennessy Jr., president of MJH Associates, parent company of OncLive®.
“We are thrilled to reach 700K page views for the month October,” said Hennessy. “This is another major milestone for OncLive®, and we wouldn’t be able to be the go-to resource for oncology professionals without our incredible team.”
During the month of October, the top-performing articles that helped OncLive.com reach these page views included:
- Oncolytic Virus Explored in Advanced HCC
- Olaparib Substantially Improves PFS as Frontline Maintenance in Ovarian Cancer
- Olaparib Substantially Improves PFS as Frontline Maintenance in Ovarian CancerFDA Approves Talazoparib for BRCA-Mutated, HER2-Negative Breast Cancer
“Reaching a new monthly web traffic record really shows that OncLive® is consistently growing to be the best of the best,” said Robert Goldsmith, vice president of OncLive®. “We are so honored that we are able to provide clinicians with the resources they need in order to provide the best patient care.”
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates Inc. Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.